The metabolism of glycosaminoglycans is impaired in prion diseases

It is well established that the conversion of PrPC to PrPSc is the key event in prion disease biology. In addition, several lines of evidence suggest that glycosaminoglycans (GAGs) and in particular heparan sulfate (HS) may play a role in the PrPC to PrPSc conversion process. It has been proposed th...

Full description

Saved in:
Bibliographic Details
Published in:Neurobiology of disease 2005-12, Vol.20 (3), p.738-743
Main Authors: Mayer-Sonnenfeld, Tehila, Zeigler, Marsha, Halimi, Michele, Dayan, Yael, Herzog, Christian, Lasmezas, Corinne I., Gabizon, Ruth
Format: Article
Language:English
Subjects:
Animals
Brain - metabolism
Brain - pathology
Brain - physiopathology
Creutzfeldt-Jakob Syndrome - genetics
Creutzfeldt-Jakob Syndrome - physiopathology
Creutzfeldt-Jakob Syndrome - urine
Cricetinae
Disease Models, Animal
Enzyme Activation - genetics
Glycosaminoglycans
Glycosaminoglycans - urine
Hexosaminidases - metabolism
Humans
Lysosomes - metabolism
Male
Metabolism
Mice
Mice, Knockout
Neurons - metabolism
Prion diseases
Prion Diseases - genetics
Prion Diseases - physiopathology
Prion Diseases - urine
PrPC Proteins - genetics
PrPC Proteins - metabolism
PrPSc Proteins - metabolism
Scrapie - genetics
Scrapie - physiopathology
Scrapie - urine
Sheep
Up-Regulation - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:It is well established that the conversion of PrPC to PrPSc is the key event in prion disease biology. In addition, several lines of evidence suggest that glycosaminoglycans (GAGs) and in particular heparan sulfate (HS) may play a role in the PrPC to PrPSc conversion process. It has been proposed that PrPSc accumulation in prion diseases may induce aberrant activation of lysosomal activity, which has been shown to result in neurodegeneration in a number of diseases, especially lysosomal storage disorders. Among such diseases, only the ones resulting from defects in GAGs degradation are accompanied by secretion of large amounts of GAG metabolites in urine. In this work, we show that GAGs are secreted in the urine of prion-infected animals and humans, and surprisingly, also in the urine of mice ablated for the PrP gene. We hypothesize that both the presence of PrPSc or the absence of PrPC may alter the metabolism of GAGs.
ISSN:0969-9961
1095-953X
DOI:10.1016/j.nbd.2005.05.009